Latest Australian Markets News

Page 3 of 22
Peet Limited has reported a robust half-year performance with statutory profit doubling and a significant dividend increase, underpinned by strong sales and settlements across key Australian markets.
Eva Park
Eva Park
19 Feb 2026
Marimaca Copper has successfully raised C$409 million through a dual Canadian and Australian equity offering, positioning the company to advance its flagship Marimaca Project and exploration at Pampa Medina.
Maxwell Dee
Maxwell Dee
19 Feb 2026
NAOS Emerging Opportunities Company Limited has reported a robust half-year profit increase of 103%, alongside a fully franked interim dividend of 2.10 cents per share, reflecting strong portfolio performance and market confidence.
Claire Turing
Claire Turing
19 Feb 2026
NAOS Small Cap Opportunities Company Limited reported a remarkable half-year profit surge and declared a steady quarterly dividend, despite portfolio returns lagging the benchmark index.
Claire Turing
Claire Turing
19 Feb 2026
Solvar Limited reported a 5.8% rise in net profit for the half year ending December 2025, driven by strategic asset sales and expanded funding facilities. The company declared both interim and special dividends, signalling confidence despite ongoing regulatory challenges.
Claire Turing
Claire Turing
18 Feb 2026
Dexus has reported a strong half-year result with a $348.5 million profit turnaround, robust leasing growth, and strategic capital moves including a $950 million equity raise and a 10% on-market buyback.
Eva Park
Eva Park
18 Feb 2026
Pureprofile Limited has agreed to acquire CRNRSTONE, an established Australian qualitative research firm, for $700,000 in cash, enhancing its market research capabilities and expected to be earnings accretive from year one.
Victor Sage
Victor Sage
17 Feb 2026
BTC Health’s investee, BTC Cardio, has landed exclusive Australian distribution rights for Jafron Biomedical’s hemoperfusion cartridges, aiming for a 2026 market debut pending regulatory approval.
Ada Torres
Ada Torres
13 Feb 2026
Dusk Group Limited reported a solid first half of FY26 with total sales rising 5.1% to $91.8 million, underpinned by product innovation and a successful AfterGlow store format trial. The company also announced a fully franked interim dividend of 4.0 cents per share.
Logan Eniac
Logan Eniac
13 Feb 2026
Centuria Industrial REIT (ASX – CIP) reported a robust HY26 with strong income growth, portfolio valuation gains, and an upgraded full-year earnings forecast, underpinned by active leasing and strategic capital management.
Eva Park
Eva Park
11 Feb 2026
Algorae Pharmaceuticals has secured a key Licence & Supply Agreement with Cadila Pharmaceuticals to commercialise two generic cardiovascular and metabolic medicines in Australia and New Zealand, broadening its therapeutic reach beyond oncology.
Victor Sage
Victor Sage
9 Feb 2026
TradeWindow reports solid growth in recurring revenue and average revenue per customer but lowers its FY26 trading revenue guidance due to softer transactional volumes in Q3.
Sophie Babbage
Sophie Babbage
30 Jan 2026